Coulter & Justus Financial Services, LLC Novartis Ag Transaction History

Coulter & Justus Financial Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$80.03 - $92.81 $50,178 - $58,191	-627 Reduced 22.31%	2,183 $200,000
Q3 2022 Nov 01, 2022	BUY	$74.61 - $87.26 $14,922 - $17,452	200 Added 7.66%	2,810 $214,000
Q2 2022 Jul 29, 2022	BUY	$80.52 - $93.75 $210,157 - $244,687	2,610 New	2,610 $221,000
Q1 2022 May 06, 2022	SELL	$80.11 - $90.62 $209,087 - $236,518	-2,610 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$79.7 - $88.13 $208,017 - $230,019	2,610 New	2,610 $228,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Coulter & Justus Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Coulter & Justus Financial Services, LLC with notifications on news.